Herko Grubitzsch

Aortic valve replacement with new-generation stentless pericardial valves: short-term clinical and hemodynamic results.

Ablation of atrial fibrillation in valvular heart surgery: are results determined by underlying valve disease?

Concomitant ablation of atrial fibrillation: are results associated with surgeon's experience?

The role of atrial remodeling for ablation of atrial fibrillation.

Concomitant ablation of atrial fibrillation in octogenarians: an observational study.

Factors predicting the time until atrial fibrillation recurrence after concomitant left atrial ablation.

Recombinant activated factor VII for treatment of refractory hemorrhage after surgery for acute aortic dissection.

Surgical-transcatheter approach for endocarditis of a calcified aortic homograft.

Outcome after surgery for prosthetic valve endocarditis and the impact of preoperative treatment.

Early administration of levosimendan is associated with improved kidney function after cardiac surgery - a retrospective analysis.

Clinical and haemodynamic outcomes in 804 patients receiving the Freedom SOLO stentless aortic valve: results from an international prospective multicentre study.

Hemodynamic behavior of stentless aortic valves in long term follow-up.

Early levosimendan administration is associated with decreased mortality after cardiac surgery.

High central venous saturation after cardiac surgery is associated with increased organ failure and long-term mortality: an observational cross-sectional study.

Surgery for prosthetic valve endocarditis: associations between morbidity, mortality and costs.

Wrinkles, folds and calcifications: Reduced durability after transcatheter aortic valve-in-valve replacement.

Severe Aortic Valve Stenosis in Adults is Associated with Increased Levels of Circulating Intermediate Monocytes.

Risks and Challenges of Surgery for Aortic Prosthetic Valve Endocarditis.

Hemodynamics of Pericardial Aortic Valves: Contemporary Stented versus Stentless Valves in a Matched Comparison.

Levels of Circulating Intermediate Monocytes Decrease after Aortic Valve Replacement in Patients with Severe Aortic Stenosis.

Long-term results after the Ross procedure with the decellularized AutoTissue Matrix P® bioprosthesis used for pulmonary valve replacement.